Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR

被引:38
作者
Coupry, I
Monnet, L
Attia, AAM
Taine, L
Lacombe, D
Arveiler, B
机构
[1] Univ Victor Segalen Bordeaux 2, Lab Genet Humaine Dev & Canc, F-33076 Bordeaux, France
[2] CHU Bordeaux, Serv Genet Med, Bordeaux, France
关键词
Rubinstein-Taybi syndrome; RTS; CBP; CREBBP; quantitative real-time PCR; RT-QPCR;
D O I
10.1002/humu.20001
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Rubinstein-Taybi syndrome (RTS) is a well,defined syndrome characterized by facial abnormalities, broad thumbs, broad big toes, and growth and mental retardation as the main clinical features. RTS was shown to be associated with disruption of the CREB-binding protein gene CBP (CREBBP), either by gross chromosomal rearrangements or by point mutations. Translocations and inversions involving chromosome band 16p13.3 form the minority of CBP mutations, whereas microdeletions occur more frequently (about 10%). Most deletion studies in RTS are performed by FISH analysis, and five cosmids must be used to cover the whole of the CBP gene, which spreads over 150 kb. Here we report the design of gene dosage assays by real-time quantitative PCR that are targeted on three exons located respectively at the 5' end (exon 2), in the middle (exon 12), and at the 3' end (exon 30) of the CBP gene. This technique proved to be efficient and powerful in finding deletions and complementary to the other available techniques, since it allowed us to identify deletions at the 3' end of the gene that had been missed by FISH analysis, and to refine some deletion breakpoints. Our results therefore suggest that real-time quantitative PCR is a useful technique to be included in the deletion search in RTS patients. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:278 / 284
页数:7
相关论文
共 28 条
  • [1] Blough RI, 2000, AM J MED GENET, V90, P29, DOI 10.1002/(SICI)1096-8628(20000103)90:1<29::AID-AJMG6>3.0.CO
  • [2] 2-Z
  • [3] Rapid detection of noval BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments
    Casilli, F
    Di Rocco, ZC
    Gad, S
    Tournier, I
    Stoppa-Lyonnet, D
    Frebourg, T
    Tosi, M
    [J]. HUMAN MUTATION, 2002, 20 (03) : 218 - 226
  • [4] PHOSPHORYLATED CREB BINDS SPECIFICALLY TO THE NUCLEAR-PROTEIN CBP
    CHRIVIA, JC
    KWOK, RPS
    LAMB, N
    HAGIWARA, M
    MONTMINY, MR
    GOODMAN, RH
    [J]. NATURE, 1993, 365 (6449) : 855 - 859
  • [5] Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome
    Coupry, I
    Roudaut, C
    Stef, M
    Delrue, MA
    Marche, M
    Burgelin, I
    Taine, L
    Cruaud, C
    Lacombe, D
    Arveiler, B
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (06) : 415 - 421
  • [6] FELKOTTER M, 2002, AM J HUM GENET, V70, P358
  • [7] Comparative multiplex dosage analysis detects whole exon deletions at the phenylalanine hydroxylase locus
    Gable, M
    Williams, M
    Stephenson, A
    Okano, Y
    Ring, S
    Hurtubise, M
    Tyfield, L
    [J]. HUMAN MUTATION, 2003, 21 (04) : 379 - 386
  • [8] Conjunction dysfunction: CBP/p300 in human disease
    Giles, RH
    Peters, DJM
    Breuning, MH
    [J]. TRENDS IN GENETICS, 1998, 14 (05) : 178 - 183
  • [9] Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3
    Giles, RH
    Petrij, F
    Dauwerse, HG
    denHollander, AI
    Lushnikova, T
    vanOmmen, GJB
    Goodman, RH
    Deaven, LL
    Doggett, NA
    Peters, DJM
    Breuning, MH
    [J]. GENOMICS, 1997, 42 (01) : 96 - 114
  • [10] The importance of gene dosage studies:: mutational analysis of the parkin gene in early-onset parkinsonism
    Hedrich, K
    Kann, M
    Lanthaler, AJ
    Dalski, A
    Eskelson, C
    Landt, F
    Schwinger, E
    Vieregge, P
    Lang, AE
    Breakefield, XO
    Ozelius, LJ
    Pramstaller, PP
    Klein, C
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (16) : 1649 - 1656